Fig. 4From: Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaBest achieved response by baseline lesion size. Best response achieved by each individual lesion compared to its size at baseline. p value refers to SLs compared to RLs and PLs in ≤4 cm lesions versus >4 cm lesions. RL Responding Lesion, SL Stable Lesion, PL Progressing LesionBack to article page